🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
601,32 USD
Máx. histórico
601,32
0 días
Split 2:1 del 23/09/2009
Caída desde máximo
En máximo
Rango 52 semanas
430,02 – 609,99
Variación hoy
+0,87%
Cierre anterior
596,13
Rango de hoy
596,14 – 606,16
Volumen hoy
595.233
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,95%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,54 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 20 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 16/09/2003 | 11,65 | 12,12 | 11,65 | 12,09 | +3,20% | 3,99% | 356.000 |
| 15/09/2003 | 11,67 | 11,98 | 11,63 | 11,71 | -0,68% | 3,00% | 438.000 |
| 12/09/2003 | 11,68 | 11,83 | 11,47 | 11,79 | +0,99% | 3,08% | 358.800 |
| 11/09/2003 | 11,56 | 11,69 | 11,45 | 11,68 | +1,08% | 2,03% | 183.400 |
| 10/09/2003 | 12,00 | 12,00 | 11,50 | 11,55 | -4,03% | 4,13% | 639.000 |
| 09/09/2003 | 12,00 | 12,16 | 11,85 | 12,04 | +0,29% | 2,54% | 605.200 |
| 08/09/2003 | 11,60 | 12,01 | 11,58 | 12,00 | +3,18% | 3,75% | 302.800 |
| 05/09/2003 | 11,55 | 12,23 | 11,50 | 11,63 | +0,69% | 6,32% | 673.800 |
| 04/09/2003 | 11,12 | 11,57 | 11,11 | 11,55 | +3,82% | 4,18% | 251.800 |
| 03/09/2003 | 11,33 | 11,52 | 11,00 | 11,13 | -2,07% | 4,59% | 532.200 |
| 02/09/2003 | 11,52 | 11,52 | 11,10 | 11,36 | -0,87% | 3,69% | 275.800 |
| 29/08/2003 | 11,34 | 11,62 | 11,25 | 11,46 | +0,75% | 3,31% | 344.400 |
| 28/08/2003 | 11,41 | 11,49 | 11,16 | 11,38 | +1,93% | 2,85% | 507.400 |
| 27/08/2003 | 10,75 | 11,16 | 10,75 | 11,16 | +2,76% | 3,81% | 597.000 |
| 26/08/2003 | 10,67 | 10,90 | 10,55 | 10,86 | +1,12% | 3,28% | 206.800 |
| 25/08/2003 | 10,65 | 10,74 | 10,49 | 10,74 | +1,85% | 2,35% | 402.600 |
| 22/08/2003 | 10,75 | 10,90 | 10,53 | 10,55 | -1,45% | 3,49% | 248.800 |
| 21/08/2003 | 10,70 | 10,95 | 10,50 | 10,70 | +0,00% | 4,21% | 454.400 |
| 20/08/2003 | 10,60 | 10,80 | 10,55 | 10,70 | +0,80% | 2,31% | 339.600 |
| 19/08/2003 | 10,58 | 10,68 | 10,48 | 10,62 | +0,76% | 1,89% | 266.000 |
| 18/08/2003 | 10,00 | 10,55 | 10,00 | 10,54 | +3,28% | 5,50% | 344.000 |
| 15/08/2003 | 10,25 | 10,29 | 10,08 | 10,20 | -0,78% | 2,05% | 151.200 |
| 14/08/2003 | 10,05 | 10,28 | 9,92 | 10,28 | +3,06% | 3,58% | 306.400 |
| 13/08/2003 | 10,18 | 10,18 | 9,85 | 9,98 | -1,92% | 3,19% | 293.400 |
| 12/08/2003 | 10,01 | 10,17 | 9,95 | 10,17 | +1,70% | 2,20% | 445.000 |
| 11/08/2003 | 9,58 | 10,00 | 9,58 | 10,00 | +3,52% | 4,44% | 492.400 |
| 08/08/2003 | 9,31 | 9,70 | 9,31 | 9,66 | +3,76% | 4,19% | 674.000 |
| 07/08/2003 | 9,23 | 9,42 | 9,23 | 9,31 | +0,11% | 2,06% | 201.800 |
| 06/08/2003 | 9,03 | 9,41 | 9,00 | 9,30 | +2,54% | 4,54% | 394.600 |
| 05/08/2003 | 8,75 | 9,25 | 8,65 | 9,07 | -2,79% | 6,86% | 1.979.400 |